12 mayo 2015
Fixed-dose drug combinations which have not received central regulatory approval are sold in substantial numbers in India — despite concerns over the safety and efficacy of these combinations — according to new research.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/QlMC4OJwuWY/150512150024.htm
